thiazoles has been researched along with Staphylococcal Infections in 57 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 12 (21.05) | 18.7374 |
1990's | 9 (15.79) | 18.2507 |
2000's | 4 (7.02) | 29.6817 |
2010's | 28 (49.12) | 24.3611 |
2020's | 4 (7.02) | 2.80 |
Authors | Studies |
---|---|
Akhir, A; Chopra, S; Goel, A; Kaul, G; Rawat, KS; Rode, HB; Sangu, KG; Sharma, CP; Shukla, M | 1 |
Akbar, S; Ganapathi, T; Ganesh Kumar, C; Kamal, A; Khan, I; Nagendra Babu, B; Sayeed, IB; Shareef, MA; Sirisha, K | 1 |
Abutaleb, NS; Elsebaei, MM; Hagras, M; Li, D; Mahgoub, AA; Mayhoub, AS; Mohammad, H; Seleem, MN | 1 |
Kirmusaoglu, S | 1 |
Abutaleb, NS; Alhashimi, M; Kassab, AE; Mayhoub, AS; Mohamed, KO; Seleem, MN; Shahin, IG; Taher, AT | 1 |
Ahmed, N; Ali, S; Farooq, S; Hussain, M; Khan, MA; Khan, S; Shamim, S | 1 |
Lan, D; Qi, G; Zhao, G | 1 |
Abouf, M; Abutaleb, NS; Chen, L; Elsebaei, MM; Ghiaty, A; Hegazy, YA; Malwal, SR; Mayhoub, AS; Mohammad, H; Oldfield, E; Seleem, MN; Zhang, J | 1 |
Abutaleb, NS; Bayoumi, A; Ghiaty, A; Hagras, M; Kotb, A; Mayhoub, AS; Mohammad, H; Seleem, MA; Seleem, MN | 1 |
Barraja, P; Carbone, A; Cascioferro, S; Cirrincione, G; Cusimano, MG; Diana, P; Montalbano, A; Parrino, B; Schillaci, D; Spanò, V | 1 |
Abdel-Aleem, JA; Abutaleb, NS; Ali, AO; Elsebaei, MM; Hagras, M; Mayhoub, AS; Seleem, MN | 1 |
Hagiya, H; Kokado, R; Okuno, H; Tomono, K | 1 |
Beaufrère, H; Field, CL; MacLean, R; Rademacher, N; Wakamatsu, N | 1 |
Kaul, M; Lavoie, EJ; Mark, L; Parhi, AK; Pilch, DS; Zhang, Y | 1 |
Alm, R; Basarab, GS; Bist, S; Dangel, PB; Eakin, AE; Garner, CE; Green, O; Hauck, S; Hill, PJ; Hull, K; Illingworth, R; Manchester, JI; Rooney, M; Sherer, BA; Uria-Nickelsen, M; Zhou, F | 1 |
Jaudzems, K; Leonchiks, A; Rudevica, Z; Turks, M; Zhulenkovs, D | 1 |
Cushman, M; Mayhoub, AS; Mohammad, H; Seleem, MN | 1 |
Kaul, M; LaVoie, EJ; Lyu, YL; Mark, L; Parhi, AK; Pawlak, J; Pilch, DS; Saravolatz, LD; Saravolatz, S; Weinstein, MP; Zhang, Y | 1 |
Gong, T; Han, H; Han, S; Liu, H; Peschel, A; Qu, D; Wu, Y; Xu, T; Zhao, D; Zhao, Y | 1 |
Cushman, M; Hammac, GK; Mayhoub, AS; Mohammad, H; Monteleone, D; Reddy, PV; Seleem, MN | 1 |
Ang, W; Chang, Y; Chen, G; Li, G; Liu, Y; Long, H; Luo, Y; Sang, Z; Tang, J; Wang, Z; Wei, Y; Yang, S; Yang, T; Yang, X; Zhang, J | 1 |
Cascioferro, S; Daidone, G; Maggio, B; Raffa, D; Raimondi, MV; Schillaci, D | 1 |
Fischer, D; Hartmann, A; Kershaw, O; Lierz, M; Maier, K; Pendl, H; Prenger-Berninghoff, E; Schmidt, MJ | 1 |
Cushman, M; Mohammad, H; Seleem, MN | 1 |
Chittoor Neelakantan, S; Kuppuswamy, AA; Lowrence, RC; Makala, HV; Mani, A; Nagarajan, S; Raman, T; Subramaniapillai, SG; Ulaganathan, V | 1 |
Aiwale, ST; Baker, PJ; Barynin, VV; Bennett, JM; Brown, DR; Chauhan, PK; Collins, I; Czaplewski, LG; Errington, J; Galbraith, G; Haydon, DJ; Heal, JR; Rice, DW; Sedelnikova, SE; Sheridan, JM; Srivastava, A; Stokes, NR; Taneja, A; Ure, R | 1 |
LENZI, G; TRIA, E | 1 |
Aman, AT; Busscher, HJ; Iravati, S; Krom, BP; Nuryastuti, T; van der Mei, HC | 1 |
Beanland, J; Bennett, JM; Brown, D; Chauhan, PK; Collins, I; Czaplewski, L; Galbraith, G; Hall, R; Haydon, DJ; Henstock, V; Lancett, P; Macdonald, R; Nayal, N; Noula, C; Rockley, C; Srivastava, A; Stokes, NR; Sutariya, JK | 1 |
Brewer, JT; Bushell, SM; Deng, G; Dewhurst, JM; Dzink-Fox, J; Gangl, E; Jain, A; LaMarche, MJ; Lee, L; Leeds, JA; Lilly, M; Manni, K; Mullin, S; Neckermann, G; Osborne, C; Palestrant, D; Patane, MA; Raimondi, A; Ranjitkar, S; Rann, EM; Sachdeva, M; Shao, J; Tiamfook, S; Whitehead, L; Yu, D | 1 |
Han, SQ; Hu, J; Huang, RZ; Jiang, DB; Liu, HY; Pan, B; Qu, D; Wang, W; Wu, Y; Wu, YC; Zheng, LK; Zhu, T | 1 |
Baryshnikova, A; Benton-Perdomo, L; Caron, A; Claveau, D; Daigneault, E; Deschamps, K; Elsen, NL; Gill, CJ; Kramer, S; Landry, F; Langlois, E; Lebeau-Jacob, C; Lee, SH; Liang, L; Lu, J; Lumb, KJ; Maxwell, E; Meredith, TC; Monteiro, JM; Parthasarathy, G; Pereira, PM; Petcu, M; Pinho, MG; Ramtohul, Y; Reid, JC; Roemer, T; Sharma, S; Sillaots, S; Skorey, K; Soisson, SM; Tam, J; Tan, CM; Therien, AG; Vaillancourt, J; Wang, H; Wang-Jarantow, L; Wong, S; Wu, J | 1 |
Elsen, NL; Lu, J; Lumb, KJ; Parthasarathy, G; Reid, JC; Sharma, S; Soisson, SM | 1 |
Fenical, W; Haste, NM; Hensler, ME; Jensen, PR; Loesgen, S; Nam, SJ; Nizet, V; Sakoulas, G; Sun, P; Thienphrapa, W; Tran, DN | 1 |
Dorrestein, PC; Walsh, CT; Young, TS | 1 |
ROMANO, C | 1 |
GIUBERTONI, C | 1 |
RANGONI, AG | 1 |
CONTERNO, G; MATONE, S; PUPITA, F | 1 |
MANZOLI, U; RUBERTI, A; VALLINI, A | 1 |
PIROLI, G | 1 |
Hawser, SP | 1 |
Barrett, JF; Dorso, K; Gill, C; Herath, K; Hickey, E; Jayasuriya, H; Masurekar, P; Motyl, M; Occi, J; Overbye, KM; Singh, SB | 1 |
Ciciliato, I; Colombo, L; Ferrari, P; Goldstein, BP; Landini, P; Le Monnier, F; Marinelli, F; Montanini, N; Selva, E; Stella, S | 1 |
Connolly, RJ; Dinarello, CA; Dirkes, K; Gelfand, JA; Harris, BH; Schwaitzberg, SD | 1 |
Inoue, Y; Jinbo, Y; Kondo, H; Sakamoto, F; Taguchi, M; Tsukamoto, G | 2 |
DeJoy, SQ; Jeyaseelan, R; Kerwar, SS; Oronsky, AL; Pickett, WC; Torley, LW; Wick, MM; Wissner, A | 1 |
Broom, NJ; Elder, JS; Hannan, PC; O'Hanlon, PJ; Pons, JE; Walker, G; Wilson, J; Woodall, P | 1 |
Abson, A; Broom, NJ; Coates, PA; Elder, JS; Forrest, AK; Hannan, PC; Hicks, AJ; Masson, ND; O'Hanlon, PJ; Pearson, ND; Pons, JE; Wilson, JM | 1 |
Blizzard, TA; DiNinno, FP; Dorso, K; Epstein-Toney, JH; Gill, CJ; Hajdu, R; Hammond, GG; Hammond, ML; Heck, JV; Huber, J; Jackson, JJ; Kohler, J; Kozarich, JW; Kropp, H; Lankas, G; Pelak, BA; Ratcliffe, RW; Rosen, H; Silver, L; Sundelof, JG; Thompson, R; Wildonger, KJ; Wilkening, RR | 1 |
Beretta, G; Ferrari, P; Gastaldo, L; Goldstein, BP; Landini, P; Lorenzetti, R; Montanini, N; Ripamonti, F; Saddler, GS; Selva, E | 1 |
Reyes-Javier, PD | 1 |
Bormioli, P; D'Alessandro, A; Dominici, A; Ravagnan, L | 1 |
Micetich, RG; Raap, R | 2 |
Closier, MD; Islip, PJ | 1 |
57 other study(ies) available for thiazoles and Staphylococcal Infections
Article | Year |
---|---|
Nitazoxanide potentiates linezolid against linezolid-resistant Staphylococcus aureus in vitro and in vivo.
Topics: Anti-Bacterial Agents; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nitro Compounds; Staphylococcal Infections; Staphylococcus aureus; Thiazoles | 2022 |
Synthesis of new triazole fused imidazo[2,1-b]thiazole hybrids with emphasis on Staphylococcus aureus virulence factors.
Topics: Anti-Bacterial Agents; Biofilms; Molecular Docking Simulation; Molecular Structure; Staphylococcal Infections; Staphylococcus aureus; Structure-Activity Relationship; Thiazoles; Triazoles; Virulence Factors | 2019 |
Phenylthiazoles with nitrogenous side chain: An approach to overcome molecular obesity.
Topics: Amines; Animals; Anti-Bacterial Agents; Cell Line; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Humans; Macrophages; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Molecular Structure; Obesity; Rats; Rats, Sprague-Dawley; Staphylococcal Infections; Structure-Activity Relationship; Thiazoles | 2019 |
Improved β-Lactam Susceptibility Against ica-Dependent Biofilm-Embedded Staphylococcus aureus by 2-Aminothiazole.
Topics: Anti-Bacterial Agents; beta-Lactams; Biofilms; Drug Resistance, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Thiazoles | 2020 |
Evaluation of N-phenyl-2-aminothiazoles for treatment of multi-drug resistant and intracellular Staphylococcus aureus infections.
Topics: Animals; Anti-Bacterial Agents; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Humans; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Microsomes, Liver; Molecular Structure; Staphylococcal Infections; Structure-Activity Relationship; Thiazoles | 2020 |
Antimicrobial and synergistic activity of thiazoline derivatives in combination with conventional antibiotics against multidrug resistant Staphylococcus aureus isolated from abscess drainage samples.
Topics: Abscess; Anti-Bacterial Agents; Disk Diffusion Antimicrobial Tests; Drainage; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Ribotyping; Staphylococcal Infections; Staphylococcus aureus; Thiazoles; Thiazolidines | 2020 |
Design and development of some thiazole-based flavanoids as novel antibacterial against pathogens causing surgical site infection for possible benefit in bone trauma via inhibition of DNA gyrase.
Topics: Animals; Anti-Bacterial Agents; DNA Gyrase; Drug Design; Flavonoids; Humans; Male; Molecular Docking Simulation; Rats, Sprague-Dawley; Staphylococcal Infections; Staphylococcus aureus; Surgical Wound Infection; Thiazoles; Topoisomerase II Inhibitors | 2017 |
Alkynyl-containing phenylthiazoles: Systemically active antibacterial agents effective against methicillin-resistant Staphylococcus aureus (MRSA).
Topics: Alkynes; Animals; Anti-Bacterial Agents; Half-Life; Methicillin-Resistant Staphylococcus aureus; Mice; Microsomes, Liver; Staphylococcal Infections; Thiazoles | 2018 |
Phenylthiazoles with tert-Butyl side chain: Metabolically stable with anti-biofilm activity.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Caco-2 Cells; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Rats, Sprague-Dawley; Staphylococcal Infections; Thiazoles | 2018 |
New Thiazole Nortopsentin Analogues Inhibit Bacterial Biofilm Formation.
Topics: Anti-Bacterial Agents; Aquatic Organisms; Biofilms; Drug Resistance, Bacterial; Humans; Imidazoles; Indoles; Inhibitory Concentration 50; Staphylococcal Infections; Staphylococcus aureus; Thiazoles | 2018 |
Naphthylthiazoles: Targeting Multidrug-Resistant and Intracellular Staphylococcus aureus with Biofilm Disruption Activity.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Cell Line; Drug Design; Drug Resistance, Multiple, Bacterial; Enterococcus; Humans; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Structure-Activity Relationship; Thiazoles | 2018 |
Daptomycin-associated myopathy induced by concomitant administration of mirabegron.
Topics: Acetanilides; Anti-Bacterial Agents; Daptomycin; Female; Humans; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Muscular Diseases; Staphylococcal Infections; Thiazoles; Urological Agents | 2019 |
Discospondylitis caused by Staphylococcus aureus in an African black-footed penguin (Spheniscus demersus).
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Bird Diseases; Doxycycline; Female; Itraconazole; Meloxicam; Spheniscidae; Spondylitis; Staphylococcal Infections; Thiazines; Thiazoles | 2012 |
An FtsZ-targeting prodrug with oral antistaphylococcal efficacy in vivo.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Benzamides; Biological Availability; Biotransformation; Chlorocebus aethiops; Cytoskeletal Proteins; Female; Half-Life; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Prodrugs; Pyridines; Staphylococcal Infections; Thiazoles; Vero Cells | 2013 |
Optimization of pyrrolamide topoisomerase II inhibitors toward identification of an antibacterial clinical candidate (AZD5099).
Topics: Adenosine Triphosphatases; Amides; Animals; Anti-Bacterial Agents; Crystallography, X-Ray; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Mice; Mice, Knockout; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Pyrroles; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Structure-Activity Relationship; Thiazoles; Topoisomerase II Inhibitors | 2014 |
Discovery and structure-activity relationship studies of irreversible benzisothiazolinone-based inhibitors against Staphylococcus aureus sortase A transpeptidase.
Topics: Aminoacyltransferases; Bacterial Proteins; Cysteine Endopeptidases; Enzyme Inhibitors; Fluorescence Resonance Energy Transfer; High-Throughput Screening Assays; Humans; Molecular Docking Simulation; Staphylococcal Infections; Staphylococcus aureus; Structure-Activity Relationship; Thiazoles | 2014 |
Anti-biofilm activity and synergism of novel thiazole compounds with glycopeptide antibiotics against multidrug-resistant staphylococci.
Topics: Anti-Bacterial Agents; Biofilms; Drug Resistance, Multiple, Bacterial; Drug Synergism; Glycopeptides; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Thiazoles; Vancomycin; Vancomycin Resistance | 2015 |
TXA709, an FtsZ-Targeting Benzamide Prodrug with Improved Pharmacokinetics and Enhanced In Vivo Efficacy against Methicillin-Resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Benzamides; Cells, Cultured; Cytoskeletal Proteins; Daptomycin; Dogs; Half-Life; Humans; Linezolid; Methicillin; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Prodrugs; Pyridines; Rats; Staphylococcal Infections; Thiazoles; Vancomycin | 2015 |
Antibacterial and anti-biofilm activities of thiazolidione derivatives against clinical staphylococcus strains.
Topics: Anti-Bacterial Agents; Biofilms; China; Hospitals, Teaching; Humans; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Microscopy, Confocal; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Tertiary Care Centers; Thiazoles | 2015 |
Antibacterial Characterization of Novel Synthetic Thiazole Compounds against Methicillin-Resistant Staphylococcus pseudintermedius.
Topics: Animals; Anti-Bacterial Agents; Cell Line; Cell Survival; Dog Diseases; Dogs; Lysostaphin; Methicillin; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Oxacillin; Rifampin; Staphylococcal Infections; Staphylococcus; Thiazoles; Vancomycin | 2015 |
Discovery of a Teraryl Oxazolidinone Compound (S)-N-((3-(3-Fluoro-4-(4-(pyridin-2-yl)-1H-pyrazol-1-yl)phenyl)-2-oxooxazolidin-5-yl)methyl)acetamide Phosphate as a Novel Antimicrobial Agent with Enhanced Safety Profile and Efficacies.
Topics: Acetamides; Animals; Anti-Infective Agents; Bacteria; Biological Availability; Drug Design; Ether-A-Go-Go Potassium Channels; Linezolid; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Models, Molecular; Oxazoles; Oxazolidinones; Potassium Channel Blockers; Staphylococcal Infections; Structure-Activity Relationship; Tetrazolium Salts; Thiazoles | 2015 |
Sortase A Inhibitors: Recent Advances and Future Perspectives.
Topics: Adamantane; Aminoacyltransferases; Animals; Anti-Bacterial Agents; Bacterial Adhesion; Bacterial Proteins; Benzoates; Carbolines; Cysteine Endopeptidases; Enzyme Inhibitors; Humans; Models, Molecular; Nitriles; Protein Conformation; Rhodanine; Small Molecule Libraries; Staphylococcal Infections; Staphylococcus aureus; Thiazoles; Thiones | 2015 |
Vertebral Osteomyelitis and Septic Arthritis Associated With Staphylococcus hyicus in a Juvenile Peregrine Falcon ( Falco peregrinus ).
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Infectious; Bird Diseases; Falconiformes; Fluoroquinolones; Male; Meloxicam; Osteomyelitis; Spine; Staphylococcal Infections; Staphylococcus hyicus; Thiazines; Thiazoles | 2015 |
Antibacterial Evaluation of Synthetic Thiazole Compounds In Vitro and In Vivo in a Methicillin-Resistant Staphylococcus aureus (MRSA) Skin Infection Mouse Model.
Topics: Administration, Topical; Animals; Drug Therapy, Combination; Humans; Keratinocytes; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Mupirocin; Staphylococcal Infections; Staphylococcal Skin Infections; Thiazoles | 2015 |
Dithiazole thione derivative as competitive NorA efflux pump inhibitor to curtail multi drug resistant clinical isolate of MRSA in a zebrafish infection model.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Bacterial Proteins; Ciprofloxacin; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Enzyme Inhibitors; Gene Expression Profiling; Methicillin-Resistant Staphylococcus aureus; Multidrug Resistance-Associated Proteins; Muscles; Real-Time Polymerase Chain Reaction; Skin; Staphylococcal Infections; Thiazoles; Thiones; Treatment Outcome; Zebrafish | 2016 |
An inhibitor of FtsZ with potent and selective anti-staphylococcal activity.
Topics: Amino Acid Sequence; Animals; Anti-Bacterial Agents; Bacillus subtilis; Bacterial Proteins; Binding Sites; Cell Division; Crystallography, X-Ray; Cytoskeletal Proteins; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Ligands; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Mutation; Protein Conformation; Pyridines; Staphylococcal Infections; Staphylococcus aureus; Thiazoles; Tubulin | 2008 |
Research on the action of penicillin and vitamin BI on the development of staphylococcus in vitro.
Topics: Penicillins; Staphylococcal Infections; Staphylococcus; Thiamine; Thiazoles | 1947 |
Effect of cinnamon oil on icaA expression and biofilm formation by Staphylococcus epidermidis.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Biofilms; Drug Synergism; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Microbial Viability; Oils, Volatile; Staphylococcal Infections; Staphylococcus epidermidis; Tetrazolium Salts; Thiazoles | 2009 |
Creating an antibacterial with in vivo efficacy: synthesis and characterization of potent inhibitors of the bacterial cell division protein FtsZ with improved pharmaceutical properties.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Biological Availability; Blood Proteins; Caco-2 Cells; Cell Division; Cell Membrane Permeability; Cytoskeletal Proteins; Hepatocytes; Humans; Mice; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Pyridines; Staphylococcal Infections; Staphylococcus aureus; Structure-Activity Relationship; Thiazoles | 2010 |
In vitro and in vivo activities of novel, semisynthetic thiopeptide inhibitors of bacterial elongation factor Tu.
Topics: Animals; Anti-Bacterial Agents; Cell Line; Cell Survival; Female; Hep G2 Cells; Humans; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Molecular Structure; Peptide Elongation Factor Tu; Peptides, Cyclic; Staphylococcal Infections; Thiazoles | 2011 |
Thiazolidione derivatives targeting the histidine kinase YycG are effective against both planktonic and biofilm-associated Staphylococcus epidermidis.
Topics: Anti-Bacterial Agents; Biofilms; Histidine Kinase; Plankton; Protein Kinase Inhibitors; Protein Kinases; Staphylococcal Infections; Staphylococcus epidermidis; Thiazoles | 2012 |
Restoring methicillin-resistant Staphylococcus aureus susceptibility to β-lactam antibiotics.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Cell Division; Crystallography, X-Ray; Cytoskeletal Proteins; Disease Models, Animal; Drug Resistance, Bacterial; Drug Synergism; Gene Regulatory Networks; Guanosine Diphosphate; Imipenem; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Mutation; Protein Structure, Secondary; Protein Transport; Pyridines; Staphylococcal Infections; Thiazoles; Virulence | 2012 |
Mechanism of action of the cell-division inhibitor PC190723: modulation of FtsZ assembly cooperativity.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cytoskeletal Proteins; Humans; Molecular Docking Simulation; Protein Conformation; Protein Structure, Tertiary; Pyridines; Staphylococcal Infections; Staphylococcus aureus; Thiazoles | 2012 |
Activity of the thiopeptide antibiotic nosiheptide against contemporary strains of methicillin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Female; HeLa Cells; Humans; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Staphylococcal Infections; Streptomyces; Thiazoles; Time Factors; Vancomycin | 2012 |
Codon randomization for rapid exploration of chemical space in thiopeptide antibiotic variants.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Base Sequence; Codon; Gene Expression; Genetic Engineering; Humans; Methicillin-Resistant Staphylococcus aureus; Molecular Sequence Data; Mutagenesis; Peptides, Cyclic; Staphylococcal Infections; Streptomyces; Thiazoles | 2012 |
[FIRST CLINICAL RESULTS OF THE USE IN UROLOGY OF A NEW NITROFURAN DERIVATIVE].
Topics: Escherichia coli Infections; Humans; Nitrofurans; Proteus Infections; Pseudomonas Infections; Staphylococcal Infections; Streptococcal Infections; Thiazoles; Urinary Tract Infections; Urology | 1963 |
[CLINICAL EXPERIENCES WITH THE INTESTINAL ANTIBACTERIAL ACTIVITY OF 2ACETAMIDO-4-(5-NITRO-2-FURYL)-THIAZOLE].
Topics: Anti-Bacterial Agents; Bronchitis; Child; Dyspepsia; Enteritis; Escherichia coli Infections; Humans; Infant; Influenza, Human; Nitrofurans; Staphylococcal Infections; Thiazoles | 1963 |
[A FURTHER CONTRIBUTION TO THE THERAPY OF URINARY INFECTIONS: FURIUM].
Topics: Enterobacter aerogenes; Escherichia coli Infections; Humans; Male; Nitrofurans; Prostatitis; Proteus Infections; Pseudomonas Infections; Staphylococcal Infections; Thiazoles; Urinary Calculi; Urinary Tract Infections | 1963 |
[CLINICAL AND BACTERIOLOGICAL STUDY OF THE CHEMOTHERAPEUTIC ACTIVITY OF 2-ACETAMIDO-4-(5-NITRO-2-FURYL)-THIAZOLE].
Topics: Bacillus; Cholangitis; Cholecystitis; Cystitis; Dysentery; Dysentery, Bacillary; Enterocolitis; Escherichia coli Infections; Humans; Male; Nitrofurans; Prostatitis; Proteus Infections; Staphylococcal Infections; Thiazoles; Urethritis | 1964 |
[2-ACETAMIDO-4-(5-NITRO-2-FURYL)-THIAZOLE IN VARIOUS PICTURES OF INFECTIVE PATHOLOGY. CLINICO-LABORATORY STUDY].
Topics: Biomedical Research; Brucellosis; Drug Therapy; Escherichia coli Infections; Humans; Meningitis; Meningitis, Meningococcal; Nitrofurans; Pharmacology; Salmonella Infections; Staphylococcal Infections; Streptococcal Infections; Thiazoles | 1964 |
[On the behavior of the complementary power in toto in complications of staphylococcal pneumopathy in infancy].
Topics: Child; Complement System Proteins; Humans; Infant; Pneumonia; Quinolinium Compounds; Staphylococcal Infections; Staphylococcus; Thiazoles | 1960 |
Antibacterial drug discovery and development--SRI's 11th Annual Summit.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Cephalosporins; Clinical Trials as Topic; Drug Design; Humans; Incidence; Lipoglycopeptides; Methicillin Resistance; Minocycline; Molecular Structure; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Thiazoles; Tigecycline | 2006 |
Antibacterial evaluations of thiazomycin- a potent thiazolyl peptide antibiotic from Amycolatopsis fastidiosa.
Topics: Actinomycetales; Animals; Anti-Bacterial Agents; Drug Resistance, Bacterial; Mice; Microbial Sensitivity Tests; Mutation; Peptides; Peptides, Cyclic; Protein Synthesis Inhibitors; RNA, Ribosomal; Staphylococcal Infections; Staphylococcus aureus; Thiazoles | 2007 |
Antibiotic GE37468 A: a new inhibitor of bacterial protein synthesis. I. Isolation and characterization.
Topics: Animals; Anti-Bacterial Agents; Bacillus subtilis; Bacterial Proteins; Bacteroides fragilis; Chromatography, High Pressure Liquid; Female; Gram-Positive Bacteria; Male; Mice; Microbial Sensitivity Tests; Molecular Structure; Peptides, Cyclic; Rats; Staphylococcal Infections; Streptomyces; Thiazoles | 1995 |
Platelet activating factor-antagonist improves survival in experimental staphylococcal septicemia.
Topics: Animals; Hemodynamics; Leukocyte Count; Organophosphorus Compounds; Platelet Activating Factor; Platelet Count; Rabbits; Sepsis; Staphylococcal Infections; Staphylococcus epidermidis; Thiazoles | 1994 |
Synthesis and antibacterial activity of thiazolopyrazine-incorporated tetracyclic quinolone antibacterial agents. 2.
Topics: 4-Quinolones; Animals; Anti-Infective Agents; Gram-Negative Bacteria; Gram-Positive Bacteria; Indicators and Reagents; Magnetic Resonance Spectroscopy; Mice; Microbial Sensitivity Tests; Molecular Structure; Optical Rotation; Pyrazines; Staphylococcal Infections; Staphylococcus aureus; Structure-Activity Relationship; Thiazoles | 1994 |
Synthesis and antibacterial activity of thiazolopyrazine-incorporated tetracyclic quinolone antibacterials.
Topics: Animals; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Positive Bacteria; Male; Methicillin; Mice; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Staphylococcal Infections; Thiazoles; Topoisomerase II Inhibitors | 1994 |
Effect of CL 184,005, a platelet-activating factor antagonist in a murine model of Staphylococcus aureus-induced gram-positive sepsis.
Topics: Animals; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Enterotoxins; Interleukin-6; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Organophosphorus Compounds; Platelet Activating Factor; Staphylococcal Infections; Thiazoles; Time Factors; Tumor Necrosis Factor-alpha | 1994 |
The chemistry of pseudomonic acid. Part 14. Synthesis and in vivo biological activity of heterocyclyl substituted oxazole derivatives.
Topics: Animals; Anti-Bacterial Agents; Furans; Humans; Isoxazoles; Mice; Mupirocin; Oxazoles; Pyrazoles; Pyridines; Sepsis; Staphylococcal Infections; Thiazoles; Thiophenes | 1995 |
Chemistry of pseudomonic acid. Part 16. Aryl and heteroaryl ketone derivatives of monic acid.
Topics: Animals; Anti-Bacterial Agents; Humans; Ketones; Male; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Mupirocin; Sepsis; Staphylococcal Infections; Structure-Activity Relationship; Thiazoles | 1996 |
Reduced immunotoxicity and preservation of antibacterial activity in a releasable side-chain carbapenem antibiotic.
Topics: Animals; Antibodies; Bacterial Proteins; Carbapenems; Carrier Proteins; Dipeptidases; Drug Design; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus; Erythrocytes; Haptens; Hexosyltransferases; Humans; Immunodominant Epitopes; Immunoglobulin G; Lactams; Lymphocyte Activation; Macaca mulatta; Mice; Mice, Inbred DBA; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Staphylococcal Infections; Staphylococcus; Thiazoles | 1999 |
Antibiotic GE2270 a: a novel inhibitor of bacterial protein synthesis. I. Isolation and characterization.
Topics: Actinomycetales; Animals; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Proteins; Bacteroides fragilis; Gram-Positive Bacteria; Mice; Microbial Sensitivity Tests; Molecular Structure; Moraxella catarrhalis; Mycobacterium tuberculosis; Peptides; Peptides, Cyclic; Propionibacterium acnes; Protein Synthesis Inhibitors; Staphylococcal Infections; Thiazoles | 1991 |
Epicillin in the treatment of acute superficial and soft tissue infections.
Topics: Acetamides; Adult; Child; Cyclohexanes; Escherichia coli Infections; Humans; Penicillanic Acid; Penicillins; Skin Diseases, Infectious; Staphylococcal Infections; Thiazoles | 1971 |
[Hetacillin: protective action and serum and tissue levels].
Topics: Administration, Oral; Ampicillin; Animals; Escherichia coli Infections; Imidazoles; Injections, Intraperitoneal; Lethal Dose 50; Male; Mice; Penicillanic Acid; Penicillins; Rabbits; Staphylococcal Infections; Thiazoles; Time Factors | 1969 |
Penicillins from 3- and 5-phenylisothiazole-4-carboxylic acids and alkoxy derivatives.
Topics: Acids; Animals; Methods; Mice; Oxacillin; Penicillin G; Penicillin Resistance; Penicillins; Staphylococcal Infections; Staphylococcus; Streptococcus pneumoniae; Streptococcus pyogenes; Thiazoles | 1968 |
Penicillins and cephalosporins from isothiazolylacetic acids.
Topics: Acetates; Amides; Ampicillin; Animals; Anti-Bacterial Agents; Cephalosporins; Cephalothin; Escherichia coli; Klebsiella; Klebsiella Infections; Methods; Mice; Penicillin G; Penicillins; Salmonella; Salmonella typhi; Staphylococcal Infections; Staphylococcus; Streptococcus pneumoniae; Streptococcus pyogenes; Thiazoles | 1968 |
Nitrofuryl heterocyclics. 2.
Topics: Amides; Animals; Enterococcus faecalis; Mice; Nitrofurans; Shigella sonnei; Staphylococcal Infections; Staphylococcus; Streptococcal Infections; Thiazoles; Urea | 1971 |